As part of its annual competition, the CRS receives hundreds of applications from researchers and clinicians throughout Canada who are seeking a $120,000 2-year grant for a cancer research project. The financial support is awarded to projects retained through a rigorous selection process conducted via peer-evaluation committees, which this year were composed of 85 researchers and clinicians who generously volunteered their time.ÌýÌýÌý
We are proud to announce that four projects from GCI members were selected:Ìý
Causes and prevention - the most effective approach to reducing the risk of developing the diseaseÌý
-
Prof. Michel Tremblay: PTP-PRL2 (PTP4A2) in lymphoangiogenesis and metastasis: a novel target in cancerÌý
-
Prof. Yojiro Yamanaka: Investigating ovarian cancer susceptibility of FANCI L604F in mouse ovarian cancer modelsÌý
Treatment – the development of new treatments, including targeted or personalized therapiesÌý
-
Prof. Luke McCaffrey: Identifying tamoxifen-persistent cells to predict ER+ breast cancer outcomesÌý
-
Dr. Jonathan Spicer: Disentangling radiation-resistant lung cancer by targeting neutrophil extracellular trapsÌý
Congratulations to the four teams!ÌýÌý